Effectiveness of aflibercept in treating bevacizumab resistant macular edema
Abstract Aim Method Prospective study on patients with macular edema secondary to diabetes mellitus, retinal vein occlusion or wet AMD. All the patients enrolled in the study had partial or no response to bevacizumab represented by mild or no improvement in macular thickness SD-OCT pictu...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
university of basrah
2024-12-01
|
| Series: | Basrah Journal of Surgery |
| Subjects: | |
| Online Access: | https://bjsrg.uobasrah.edu.iq/article_185682_1b329e4e5a72a78e766bb123e1c9995c.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Abstract
Aim
Method
Prospective study on patients with macular edema secondary to diabetes mellitus, retinal vein occlusion or wet AMD.
All the patients enrolled in the study had partial or no response to bevacizumab represented by mild or no improvement in macular thickness SD-OCT pictures or less than 2 lines improvement in best corrected visual acuity before switching to intravitreal aflibercept.
Results
40 patients selected regardless their age, sex, & diabetic control relatively, but all of them had macular edema resistant to repeated intravitreal bevacizumab injection anatomically & clinically.
Most of patients showed good response to aflibercept intravitreal injection, either from the first or repeated injection.
Conclusion
Aflibercept show good functional & anatomical improvement in macular edema not responding to frequent bevacizumab injection.
To evaluate the ability of aflibercept in the treatment of resistant macular edema after repeated intravitreal bevacizumab injection. |
|---|---|
| ISSN: | 1683-3589 2409-501X |